Vilget-M Tablets

Vilget-M Tablets – Dual-Pathway Glycemic Control

Vilget-M is a potent combination anti-diabetic medication that unites Vildagliptin and Metformin HCl to provide comprehensive blood sugar management for adults with type 2 diabetes mellitus (T2DM). It is primarily indicated as an adjunct to diet and exercise for patients who are not adequately controlled on metformin monotherapy. This medication is also used in triple combination therapy with a sulfonylurea or as an add-on to insulin therapy when additional glycemic control is required. Vildagliptin works as a DPP-4 inhibitor to stimulate the pancreas to release more insulin, while Metformin improves insulin sensitivity and reduces the liver's production of glucose. This dual approach helps maintain stable blood sugar levels throughout the day and night. Taking the medication in a single combination tablet improves patient convenience and supports long-term adherence to the treatment plan. It is typically taken with meals to minimize potential gastrointestinal side effects and ensure optimal therapeutic outcomes.

• Indicated for type 2 diabetes as an adjunct to diet and exercise.
• Combines insulin secretion and sensitivity enhancement.
• Used in dual or triple combination therapy regimens.
• Available as: Tablets 50mg+500mg, 50mg+850mg, and 50mg+1000mg.